Annelise Yoo Mah-Som, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alkyl and Aryl Transferases | 1 | 2021 | 89 | 0.730 |
Why?
|
| Muscular Diseases | 1 | 2023 | 551 | 0.640 |
Why?
|
| Antigens | 1 | 2021 | 1437 | 0.500 |
Why?
|
| Killer Cells, Natural | 4 | 2024 | 2206 | 0.470 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7850 | 0.230 |
Why?
|
| Muromegalovirus | 2 | 2021 | 31 | 0.220 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 130 | 0.210 |
Why?
|
| Muscle Hypotonia | 1 | 2023 | 166 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 334 | 0.190 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2536 | 0.190 |
Why?
|
| Adenylate Kinase | 1 | 2021 | 100 | 0.180 |
Why?
|
| Microcephaly | 1 | 2024 | 427 | 0.170 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2023 | 547 | 0.170 |
Why?
|
| Calcium Carbonate | 1 | 2018 | 62 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2024 | 2590 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2024 | 2136 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3584 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2221 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 837 | 0.120 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1377 | 0.110 |
Why?
|
| Ligands | 1 | 2021 | 3274 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2021 | 2667 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2057 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2019 | 2602 | 0.090 |
Why?
|
| Homeostasis | 1 | 2019 | 3338 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4887 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2019 | 3079 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2018 | 1966 | 0.070 |
Why?
|
| Phenotype | 2 | 2024 | 16716 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22341 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3942 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10433 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 12803 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3787 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 268 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 81839 | 0.050 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2019 | 13 | 0.040 |
Why?
|
| Animals | 5 | 2024 | 168800 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2019 | 178 | 0.040 |
Why?
|
| Syndrome | 1 | 2024 | 3270 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 651 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2018 | 312 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 2039 | 0.030 |
Why?
|
| Psoriasis | 1 | 2024 | 922 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 1630 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1996 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6215 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4263 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 766117 | 0.020 |
Why?
|
| Genotype | 1 | 2024 | 13028 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2024 | 6612 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 223139 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5747 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23605 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15546 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 16040 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18076 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 17071 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2024 | 42511 | 0.010 |
Why?
|
| Male | 3 | 2024 | 363935 | 0.010 |
Why?
|
| Female | 3 | 2024 | 396233 | 0.010 |
Why?
|
| Child | 1 | 2024 | 80573 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 88819 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21074 | 0.010 |
Why?
|